Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.

Literature DB >> 8669117

Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.

P Grossi¹, S Kusne, C Rinaldo, K St George, M Magnone, J Rakela, J Fung, T E Starzl.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1996 PMID： 8669117 PMCID： PMC2967378 DOI： 10.1097/00007890-199606150-00022

Source DB: PubMed Journal: Transplantation ISSN： 0041-1337 Impact factor: 4.939

× No keyword cloud information.

14 in total

Review 1. Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors: T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal: Transplantation Date: 1992-08 Impact factor: 4.939

2. TRANSPLANTATION PNEUMONIA.

Authors: D RIFKIND; T E STARZL; T L MARCHIORO; W R WADDELL; D T ROWLANDS; R B HILL
Journal: JAMA Date: 1964-09-14 Impact factor: 56.272

3. Preemptive therapy in immunocompromised hosts.

Authors: R H Rubin
Journal: N Engl J Med Date: 1991-04-11 Impact factor: 91.245

Review 4. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors: T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal: Hepatology Date: 1993-06 Impact factor: 17.425

5. Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.

Authors: M G Revello; E Percivalle; M Zavattoni; M Parea; P Grossi; G Gerna
Journal: J Med Virol Date: 1989-10 Impact factor: 2.327

6. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

Authors: D R Snydman; B G Werner; N N Dougherty; J Griffith; R H Rubin; J L Dienstag; R H Rohrer; R Freeman; R Jenkins; W D Lewis; S Hammer; E O'Rourke; G F Grady; K Fawaz; M M Kaplan; M A Hoffman; A T Katz; M Doran
Journal: Ann Intern Med Date: 1993-11-15 Impact factor: 25.391

7. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.

Authors: J Taylor-Wiedeman; J G Sissons; L K Borysiewicz; J H Sinclair
Journal: J Gen Virol Date: 1991-09 Impact factor: 3.891

8. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.

Authors: E Percivalle; M G Revello; L Vago; F Morini; G Gerna
Journal: J Clin Invest Date: 1993-08 Impact factor: 14.808

9. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.

Authors: W van der Bij; J Schirm; R Torensma; W J van Son; A M Tegzess; T H The
Journal: J Clin Microbiol Date: 1988-12 Impact factor: 5.948

10. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Authors: G Gerna; M G Revello; E Percivalle; F Morini
Journal: J Clin Microbiol Date: 1992-05 Impact factor: 5.948

12 in total

1. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.

Authors: K St George; M J Boyd; S M Lipson; D Ferguson; G F Cartmell; L H Falk; C R Rinaldo; M L Landry
Journal: J Clin Microbiol Date: 2000-04 Impact factor: 5.948

2. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.

Authors: Raymund R Razonable; Carlos V Paya; Thomas F Smith
Journal: J Clin Microbiol Date: 2002-03 Impact factor: 5.948

3. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation.

Authors: Xiaoli L Pang; Linda Chui; Jayne Fenton; Barbara LeBlanc; Jutta K Preiksaitis
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

4. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

Authors: N Singh; V L Yu
Journal: Dig Dis Sci Date: 1998-06 Impact factor: 3.199

5. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.

Authors: G Gerna; M Zavattoni; E Percivalle; P Grossi; M Torsellini; M G Revello
Journal: J Clin Microbiol Date: 1998-04 Impact factor: 5.948

6. Tacrolimus in pediatric renal transplantation.

Authors: R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal: Transplantation Date: 1996-12-27 Impact factor: 4.939

7. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

Authors: G Gerna; F Baldanti; J M Middeldorp; M Furione; M Zavattoni; D Lilleri; M G Revello
Journal: J Clin Microbiol Date: 1999-04 Impact factor: 5.948